{"id":"NCT00976391","sponsor":"GlaxoSmithKline","briefTitle":"A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine","officialTitle":"A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared With the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2011-10","completion":"2012-05","firstPosted":"2009-09-14","resultsPosted":"2014-07-16","lastUpdate":"2017-01-11"},"enrollment":586,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"BIOLOGICAL","name":"albiglutide + insulin glargine","otherNames":[]},{"type":"DRUG","name":"insulin glargine + preprandial lispro insulin","otherNames":[]}],"arms":[{"label":"albiglutide + insulin glargine","type":"ACTIVE_COMPARATOR"},{"label":"insulin glargine + preprandial lispro insulin","type":"ACTIVE_COMPARATOR"}],"summary":"This study will examine the safety and efficacy of albiglutide in combination with insulin glargine as compared with the combination of insulin glargine and preprandial lispro insulin in subjects with type 2 diabetes.","primaryOutcome":{"measure":"Change From Baseline (BL) in Glycosylated Hemoglobin (HbA1c) at Week 26","timeFrame":"Baseline and Week 26","effectByArm":[{"arm":"Albiglutide 30 mg With Insulin Glargine","deltaMin":-0.82,"sd":0.058},{"arm":"Preprandial Lispro Insulin With Insulin Glargine","deltaMin":-0.66,"sd":0.058}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":24},"locations":{"siteCount":209,"countries":["United States","Brazil","France","Germany","Hong Kong","India","Mexico","Peru","Philippines","South Africa","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["24898300"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":285},"commonTop":["Nasopharyngitis","Diarrhoea","Urinary Tract Infection","Upper Repiratory Tract Infection","Nausea"]}}